| Literature DB >> 32665658 |
Mohammad Nooranidoost1, Ranganathan Kumar2.
Abstract
Encapsulated cell therapy has shown great potential in the treatment of several forms of cancer. Microencapsulation of these cancer cells can protect the core from the harmful effects of the neighboring cellular environment and can supply nutrients and oxygen. Such an encapsulation technique ensures cell viability and enables targeted drug delivery in cancer therapy. The cells immobilized with a biocompatible shell material can be isolated from the ambient and can move in constricted microcapillary. However, transportation of these cells through the narrow microcapillary may squeeze and mechanically damage the cells which threaten the cell viability. The cell type, conditions and the viscoelastic properties of the shell can dictate cell viability. A front-tracking numerical simulation shows that the engineered shell material with higher viscoelasticity improves the cell viability. It is also shown that low cortical tension of cells can contribute to lower cell viability.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32665658 PMCID: PMC7360627 DOI: 10.1038/s41598-020-67739-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1(a) Computational setup. (b) Schematic illustration of the simulation setup. In region II, both cell and shell fluid droplet deform while passing through the contraction. The cell inside the encapsulating droplet moves faster than the droplet due to the pressure loss and therefore, the cell moves to the front end of the droplet.
Summary of properties for cells, shell fluid and extracellular fluid.
| Cell type | Encapsulating droplet | Extracellular fluid | ||||
|---|---|---|---|---|---|---|
| HL60 | Neutrophil | Jurkat | Newtonian shell fluid | Viscoelastic shell fluid | FC-40 oil | |
| Density[ | ||||||
| Diameter[ | 12.4 | 8.3 | 11.5 | 36 | 36 | − |
| Cortical tension[ | 155 | 48 | 21 | − | − | − |
| Polymeric viscosity ratio [ | 0.7 | 0.7 | 0.7 | − | 0.1–0.5 | − |
| Total viscosity [ | 40 | 40 | 40 | 2 | 2 | 4 |
| Relaxation time[ | 0.17 | 0.17 | 0.17 | − | 0.1 | − |
The parameter values are obtained from the references indicated in the table.
Figure 2Shape evolution of an encapsulated HL60 through the constricted microchannel at different locations of channel. Velocity vectors are shown in blue to represent the flow dynamics. The red gradient colorbar and contours represent the square root of trace of conformation tensor inside the cell. The viscoelasticity is high around the cell membrane (Ca = 0.00076 and Re = 0.37).
Figure 3Deformation of different leukemia cells through a constricted microchannel (Ca = 0.00076 and Re = 0.37).
Figure 4Shape evolution of an encapsulated HL60 through the constricted microchannel at different locations of channel. The shell fluid is Newtonian () indicated by blue on the bottom half; the viscoelastic shell fluid () is indicated by red on the top half. The color bar and contours represent the square root of tensor of conformation tensor inside the cell and the shell fluid ( and ).
Figure 5Shape evolution of an encapsulated Jurkat through the constricted microchannel at different locations of channel. The shell fluid is Newtonian () indicated by blue on the bottom half; the viscoelastic shell fluid () is indicated by red on the top half. The color bar and contours represent the square root of trace of conformation tensor inside the cell and the shell fluid ( and ).
Figure 6Deformation of (a) HL60, (b) Neutrophil and (c) Jurkat cells at different polymeric concentrations for and .
Figure 7Position of cell and pressure field inside the encapsulating droplet at (a) region I: before contraction, (b) region II: within the contraction and (c) region III: after the contraction. The color bar and contours represent the pressure field inside the encapsulating droplet.
Figure 8Viability of HL60, Neutrophil and Jurkat cells at different polymeric concentrations for and .